Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Sunshine Biopharma (SBFM) Shares Outstanding (2016 - 2025)

Sunshine Biopharma's Shares Outstanding history spans 14 years, with the latest figure at $4.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 90.15% year-over-year to $4.9 million; the TTM value through Dec 2025 reached $4.9 million, up 90.15%, while the annual FY2025 figure was $4.9 million, 90.15% up from the prior year.
  • Shares Outstanding reached $4.9 million in Q4 2025 per SBFM's latest filing, up from $4.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $18.9 million in Q2 2022 to a low of $10000.0 in Q3 2022.
  • Average Shares Outstanding over 5 years is $2.7 million, with a median of $1.5 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: plummeted 99.95% in 2023, then soared 19896.6% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $1.0 million in 2021, then plummeted by 99.0% to $10000.0 in 2022, then skyrocketed by 40.12% to $14012.0 in 2023, then soared by 18313.49% to $2.6 million in 2024, then soared by 90.15% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Shares Outstanding are $4.9 million (Q4 2025), $4.6 million (Q3 2025), and $4.6 million (Q2 2025).